Medication can be a powerful healing substance to treat or prevent disease, infections, and other health-related complications. However, medication cannot fulfill its purpose if it is not taken. There are many reasons why patients nationwide avoid taking it, simply from inadvertently neglecting or facing its side effects.
Gabriel Levitt, President of Prescription Justice submitted comments to the Food and Drug Administration (FDA) in response to the Notice of Proposed Rulemaking (NPRM) titled "Importation of Prescription Drugs, FDA-2019-N-5711, 84 Fed. Reg. 70796.
Prescription Justice founder Gabriel Levitt submitted the comments below in response to the FDA’s request for comments on its draft guidance related to “Importation of Certain FDA-Approved Human Prescription Drugs, Including Biological Products, under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act: Draft Guidance for Industry.”
Elizabeth, who is from California, periodically gets migraine headaches. To treat them, she is prescribed brand name Relpax (elitriptan), but finds that the drug is too expensive in the U.S., so she chooses to import the same drug at a much lower price. Despite federal restrictions, most medicines that are imported for personal use reach the patient. But not always. In Elizabeth’s case, instead of receiving her medication, the Food and Drug Administration (FDA) destroyed the medication after it was detained at an international mail facility (IMF). She gave Prescription Justice the green light to tell her story.
Earlier this week, Prescription Justice founder Gabriel Levitt published an article in The Nation entitled, “Is the FDA Misleading Congress About the Safety of Imported Medicines?”. While we advocate for policies and legislative reforms to bring down drug prices here in the U.S., the article highlights the fact that personal prescription drug importation is already a lifeline for millions of Americans who can’t afford their medications here.